Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum.
about
Diversity of microbial sialic acid metabolismStructural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitRegulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactatePhase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation.Identification of a lipopolysaccharide alpha-2,3-sialyltransferase from Haemophilus influenzae.Haemophilus ducreyi produces a novel sialyltransferase. Identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide.Insights into the evolution of sialic acid catabolism among bacteria.Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in GonococciIncorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defensesStrategies for mimicking Neisserial saccharide epitopes as vaccines.Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tractHeparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum.Expression of sialyltransferase is not required for interaction of Neisseria gonorrhoeae with human epithelial cells and human neutrophilsPelvic inflammatory disease isolates of Neisseria gonorrhoeae are distinguished by C1q-dependent virulence for newborn rats and by the sac-4 regionThe lipooligosaccharides of Haemophilus ducreyi are highly sialylated.Gonococci in vivo: Host CMP-NANA, sialylated lipopolysaccharide and serum resistanceUse of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesisHost-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo.The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistanceEndogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.Covalent modification of Lys19 in the CTP binding site of cytidine 5'-monophosphate N-acetylneuraminic acid synthetase.In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeaePhosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.Molecular basis for serum resistance in Neisseria gonorrhoeae.Structural studies of lipooligosaccharides from Haemophilus ducreyi ITM 5535, ITM 3147, and a fresh clinical isolate, ACY1: evidence for intrastrain heterogeneity with the production of mutually exclusive sialylated or elongated glycoforms.Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated.Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosisGrowth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.Sialic acid catabolism confers a competitive advantage to pathogenic vibrio cholerae in the mouse intestine.
P2860
Q24594315-EDF02BC0-6687-4170-8083-91EA3EC7A171Q28377527-451B5EF4-023F-4226-9444-F1DB1CB5A6BAQ28379258-E07E8A3B-DF2A-42F8-B38F-67C35ED8CD26Q30352495-10156DAC-E5C8-4FD1-B347-182C6CEDA4C8Q31038557-DF1034E9-4D63-4D27-9CEF-C09ECAEA4C4FQ31795714-81F33AB0-D1CB-4492-87C5-6AF18C7FC2BDQ31915813-1C8319EB-BAB8-4E91-8CED-E386759E0682Q33452919-1E1646C5-066C-458C-BD5A-2BC3FD3E1338Q33594645-E2B925BA-EF07-43DB-8CF9-DE77F4211BB1Q34008173-69930FAB-E704-4315-9D8A-21CE151084B6Q34105747-F0DE11FD-12BD-477F-90B6-C3E460C3470AQ34111593-97EEA3B2-2920-499A-A4BE-7A89578A3F33Q34129976-309294F5-8343-4B3B-8CB9-47EF69E2925DQ34219062-48CCEA46-72A2-48D1-A7E5-6BE94B686A53Q34552298-3FE60171-C792-44DA-9932-09E30C3E227FQ35063071-792F9577-DCD4-476C-A23D-B4D34904E255Q35072338-DDB0DEF6-C0A2-400C-8065-F44F5554D979Q35409397-399845AA-9D9E-4E82-9F4C-892DE2CF8EE1Q35523935-6C97E1DD-9653-4F2F-B260-A4C53350FF08Q35548614-E31A70FB-663D-4A68-A9F7-8D067402A392Q35601403-D1B8E239-F041-4773-83FC-708BC2784384Q35649893-19AD598B-0D94-4DBB-8518-033028A265C6Q35782295-685EE326-FA51-4915-A0DB-23B945D1FEB4Q35833811-04062BDF-2B2F-4211-B76D-DC90F73749D2Q35920654-EF5B4C20-B298-4321-B675-D417B6FAA2F2Q35949845-05431A42-D692-4AF2-8DFB-9E53FE262627Q36145701-4073967E-5691-4610-8377-B76970B3BF96Q36281479-D0AA36BF-8711-4A45-A4D5-C9A719D73EBFQ36351128-AD1684A1-577E-4A6D-B823-B406715E39FCQ36376189-49055EA2-8EED-435A-8CCD-06A1194CCF0EQ36400453-F4B913D9-7AF4-4109-92C2-D6D20BC22126Q36404057-04AE485D-C7CC-4667-998C-FD4C6DF4733AQ36506184-BC84D702-F9C8-4CC3-B869-E2C929D66BC3Q36634375-E719AB0D-F786-4B07-BB44-8AA3CCC05A7BQ36693540-1D6A2A50-A9EA-4C62-B713-4AA36D9148DDQ36942735-B6048925-FE4C-48A7-B816-3030074B445FQ36953132-CF02657C-7170-46E8-B824-CAFBB29CF0D0Q36955918-24054333-5144-4FF1-BDE2-AE605825DB0EQ37191341-C0E076B1-FF95-4843-BE45-7E4B3F861982Q37333420-2E8FB934-BE76-4376-8DD8-439354562C38
P2860
Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@en
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@nl
type
label
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@en
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@nl
prefLabel
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@en
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@nl
P2093
P1476
Cytidine 5'-monophospho-N-acet ...... nce to killing by human serum.
@en
P2093
Andrade JR
Parsons NJ
P304
P356
10.1016/0882-4010(88)90103-9
P577
1988-10-01T00:00:00Z